B74.8 Other filariases

Name of the Condition

• Other filariases

Summary

Other filariases represent a group of parasitic infections caused by various filarial nematodes beyond the most common species. These infections are transmitted through the bite of infected arthropods, typically mosquitoes or other vectors, and can affect different body systems, including lymphatic, subcutaneous, or ocular tissues. The clinical presentation varies depending on the specific filarial species involved and the host’s immune response, with symptoms ranging from mild to severe. The condition is endemic in tropical and subtropical regions and may present acutely or chronically.

Causes

Other filariases are caused by infection with filarial nematodes other than Wuchereria bancrofti, Brugia malayi, or Brugia timori. Transmission occurs when an infected vector (e.g., mosquito, midge, or blackfly) bites a human, introducing larval parasites into the bloodstream. The larvae mature into adult worms, which reside in specific tissues (e.g., lymphatic vessels, subcutaneous tissues, or eyes), producing microfilariae that circulate in the blood and are ingested by subsequent vectors, perpetuating the cycle.

Risk Factors

• Residence in or travel to endemic tropical/subtropical regions where filarial vectors are prevalent.
• Prolonged exposure to vector bites, particularly in areas with poor vector control.
• Lack of access to preventive measures such as insect repellent or bed nets.
• Immunocompromised states, which may increase susceptibility to severe disease.

Symptoms

• Variable depending on the specific filarial species, including subcutaneous nodules, ocular inflammation, or systemic symptoms.
• May include fever, lymphadenopathy, or localized swelling in affected tissues.
• Some infections may be asymptomatic or present with mild, nonspecific symptoms.

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory testing. Microscopic examination of blood or tissue samples may reveal microfilariae. Serological tests or molecular assays (e.g., PCR) can identify specific filarial species. Imaging studies (e.g., ultrasound, MRI) may be used to assess tissue involvement, such as lymphatic or ocular damage. A definitive diagnosis often requires correlation of clinical, epidemiological, and laboratory findings.

Treatment Options

Treatment typically involves antiparasitic medications, such as diethylcarbamazine (DEC), ivermectin, or albendazole, depending on the species and clinical severity. Supportive care may include management of inflammation, pain, or secondary infections. In cases of chronic complications (e.g., lymphedema), physical therapy or surgical intervention may be necessary. Treatment regimens should be tailored to the specific filarial species and patient factors.

Prognosis and Follow-Up

Prognosis varies by species and severity of infection. Early treatment can reduce symptoms and prevent long-term complications, but chronic infections may lead to irreversible tissue damage. Follow-up care includes monitoring for treatment response, managing complications, and preventing reinfection. Regular clinical evaluations and, if applicable, repeat testing may be recommended to ensure resolution or control of the infection.

Complications

• Chronic lymphatic damage, leading to lymphedema or elephantiasis.
• Ocular involvement, potentially causing vision impairment or blindness.
• Subcutaneous fibrosis or nodules.
• Secondary bacterial infections in affected tissues.
• Systemic reactions to dying parasites during treatment.

Lifestyle & Prevention

• Use insect repellent and wear protective clothing to avoid vector bites.
• Sleep under insecticide-treated bed nets in endemic areas.
• Avoid outdoor activities during peak vector activity times.
• Seek prompt medical evaluation for symptoms after travel to endemic regions.
• Follow public health recommendations for vector control in high-risk areas.

When to Seek Professional Help

Seek medical attention if you experience unexplained swelling, fever, or skin lesions after travel to tropical or subtropical regions. Prompt evaluation is important for early diagnosis and treatment, especially if symptoms persist or worsen. Individuals with a history of exposure to filarial vectors should consult a healthcare provider for screening if asymptomatic but at risk.

Tips for Medical Coders

When coding for other filariases (B74.8), ensure documentation specifies the filarial species or clinical manifestation (e.g., Mansonella streptocerca infection, Onchocerca volvulus-related ocular disease) to support the diagnosis. Verify that the code aligns with the specific filarial infection documented, as B74.8 is a catch-all for filariases not classified elsewhere. Confirm that the diagnosis is supported by clinical findings, exposure history, or laboratory results to meet coding guidelines.